SEVERE COVID-19

Clinical trials for SEVERE COVID-19 explained in plain language.

Never miss a new study

Get alerted when new SEVERE COVID-19 trials appear

Sign up with your email to follow new studies for SEVERE COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New drug fails to show benefit in severe COVID-19 pneumonia trial

Disease control Terminated

This study tested whether adding reparixin to standard care could prevent death or the need for a breathing machine in 414 hospitalized adults with COVID-19 or other pneumonia. The trial was stopped early. Researchers compared reparixin to a placebo to see if it reduced severe ou…

Matched conditions: SEVERE COVID-19

Phase: PHASE3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC

SEVERE COVID-19

Get alerted when new SEVERE COVID-19 trials appear

New drug fails to show benefit in severe COVID-19 pneumonia trial